Search

Your search keyword '"Kolozsvari, A"' showing total 565 results

Search Constraints

Start Over You searched for: Author "Kolozsvari, A" Remove constraint Author: "Kolozsvari, A"
565 results on '"Kolozsvari, A"'

Search Results

1. Optimizing cardiopulmonary rehabilitation duration for long COVID patients: an exercise physiology monitoring approach

2. A lay of the land: a description of academic acute care surgery models in Canada

3. Understanding International Students’ Perspective of Health Service Quality: A Cross-Sectional Study in a Hungarian University

4. IMPACTOS E PROMESSAS DA INTELIGÊNCIA ARTIFICIAL NA REVOLUÇÃO DA CIRURGIA HEPATOBILIOPANCREÁTICA

13. Three-dimensional transesophageal echocardiographic evaluation of pulmonary vein anatomy prior to cryoablation: validation with cardiac CT scan

23. Leaving child and adolescent mental health services in the MILESTONE cohort: a longitudinal cohort study on young people's mental health indicators, care pathways, and outcomes in Europe

28. Demographic, clinical, and service-use characteristics related to the clinician’s recommendation to transition from child to adult mental health services

29. Potential Clinical Usefulness of Post-Valvular Contrast Densities to Determine the Severity of Aortic Valve Stenosis Using Computed Tomography

31. Ecologies of Embodiment: Video Essays I

34. Supplementary Figure S5 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

35. Supplementary Video S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

36. Supplementary Tables S1-S19 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

37. Supplementary Methods S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

38. As estimativas dos efeitos benéficos no uso do inibidor do cotransportador Sódio-Glicose 2 (iSGLT-2) na insuficiência cardíaca com fração de ejeção reduzida

39. Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

Catalog

Books, media, physical & digital resources